Wikidata

(Q65390029)

English

Study Comparing the Zevalin Regimen With no Further Treatment in DLBCL Patients Who Are in Complete Remission After CHOP-R

clinical trial

In more languages

Statements

title
A Phase III, Open-Label, Prospective, Two-Armed, Multicenter, Randomized, Group Sequential Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) Study Regimen Versus Observation in Patients With Diffuse Large B-Cell Lymphoma Who Are in Complete Remission After First-Line CHOP-Rituximab (CHOP-R) Therapy (English)
0 references
country
Austria
0 references
Belgium
0 references
Canada
0 references
Finland
0 references
France
0 references
Germany
0 references
Hungary
0 references
Republic of Ireland
0 references
Italy
0 references
Poland
0 references
Portugal
0 references
Singapore
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
Thailand
0 references
United Kingdom
0 references
start time
May 2006
0 references
end time
December 2009
0 references
number of participants
400
0 references
minimum age
60 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65390029&oldid=2153232255"